论文部分内容阅读
目的观察盐酸依托必利治疗功能性消化不良的疗效和安全性。方法100例功能性消化不良患者随机分组,试验组50例给予盐酸依托必利片50mg一日三次;对照组50例给予多潘立酮10mg一日三次。疗程均为2周。结果2组患者功能性消化不良的症状均显著缓解,疗效相近,但餐后饱胀的改善作用试验组优于对照组。结论盐酸依托必利是治疗功能性消化不良的疗效较好,付作用较小的新一代胃肠道促动力药。
Objective To observe the efficacy and safety of etopride hydrochloride in the treatment of functional dyspepsia. Methods One hundred cases of functional dyspepsia were randomly divided into two groups. 50 cases in trial group were treated with 50 mg of etoprim hydrochloride tablets three times a day; 50 cases in control group were treated with domperidone 10 mg three times a day. The course of treatment is 2 weeks. Results The symptoms of functional dyspepsia in both groups were significantly relieved with similar curative effect, but the improvement effect of postprandial fullness was better in the experimental group than in the control group. Conclusion Etopride Hydrochloride is a new generation of gastrointestinal motility drug for treating functional dyspepsia with good curative effect and less pay.